OCT 9, 2026 · JOURNAL ARTICLE
Switching to aripiprazole reverses a high-risk metabolic syndrome subtype in schizophrenia: a 6-month prospective study
BMC Psychiatry
This study aimed to investigate the reversal of a high-risk metabolic syndrome (MetS) subtype (characterized by central obesity, hypertriglyceridemia, and low high-density lipoprot